Is it better to start biologic agents as early as possible for rheumatoid arthritis?
May 15, 2023
Source: Cainiu Health
Dr. Liu Aihua
Introduction
Rheumatoid arthritis is typically better treated with biologic agents the earlier they are administered. Rheumatoid arthritis is an autoimmune disease primarily characterized by joint inflammation, manifesting as symptoms such as joint swelling, pain, and stiffness. This inflammation results from abnormal immune responses, which can lead to immune cells attacking the body's own tissues and organs.
Rheumatoid usually refers to rheumatoid arthritis, and in general, the earlier biologic agents are administered, the better. The detailed explanation is as follows:
Rheumatoid arthritis is an autoimmune disease primarily characterized by joint inflammation, manifesting as joint swelling, pain, and stiffness. This inflammation results from abnormal immune responses, causing immune cells to attack the body's own tissues and organs. Biologic agents are medications specifically designed to treat rheumatoid arthritis by suppressing these abnormal immune responses, thereby reducing joint inflammation and pain. Early use of biologic agents can more effectively control the symptoms and progression of rheumatoid arthritis, thus minimizing joint damage and the risk of disability. Therefore, for patients with a confirmed diagnosis of rheumatoid arthritis, early treatment with biologic agents is beneficial.
It should be noted that biologic agents are potent medications and must be used strictly according to a physician’s instructions. Patients should avoid adjusting the dosage or frequency on their own. Additionally, patients should monitor for potential side effects of biologic agents and seek medical attention promptly if any adverse reactions occur.
